Authors:
Konecny, G
Untch, M
Pihan, A
Kimmig, R
Gropp, M
Stieber, P
Hepp, H
Slamon, D
Pegram, M
Citation: G. Konecny et al., Association of urokinase-type plasminogen activator and its inhibitor withdisease progression and prognosis in ovarian cancer, CLIN CANC R, 7(6), 2001, pp. 1743-1749
Authors:
Lein, M
Jung, K
Hammerer, P
Graefen, M
Semjonow, A
Stieber, P
Ossendorf, M
Luboldt, HJ
Brux, B
Stephan, C
Schnorr, D
Loening, SA
Citation: M. Lein et al., A Multicenter Clinical Trial on the use of alpha(1)-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis, PROSTATE, 47(2), 2001, pp. 77-84
Authors:
Sreejayan, N
Wittig, BM
Von Stillfried, N
Hennicke, MS
Meyer, G
Stieber, P
Lamerz, R
Von Ritter, C
Citation: N. Sreejayan et al., Human biliary mucin binds to E-selectin: a possible role in modulation of inflammation, AM J P-GAST, 280(5), 2001, pp. G1043-G1048
Authors:
Holdenrieder, S
Stieber, P
Bodenmuller, H
Busch, M
Fertig, G
Furst, H
Schalhorn, A
Schmeller, N
Untch, M
Seidel, D
Citation: S. Holdenrieder et al., Nucleosomes in serum of patients with benign and malignant diseases. (vol 95, pg 114, 2001), INT J CANC, 95(6), 2001, pp. 398-398
Authors:
Semjonow, A
Oberpenning, F
Weining, C
Schon, M
Brandt, B
De Angelis, G
Heinecke, A
Hamm, M
Stieber, P
Hertle, L
Schmid, HP
Citation: A. Semjonow et al., Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer?, CLIN CHEM, 47(8), 2001, pp. 1472-1475
Authors:
Stieber, P
Molina, R
Chan, DW
Fritsche, HA
Beyrau, R
Bonfrer, JMG
Filella, X
Gornet, TG
Hoff, T
Jager, W
van Kamp, GJ
Nagel, D
Peisker, K
Sokoll, LJ
Troalen, F
Untch, M
Domke, I
Citation: P. Stieber et al., Evaluation of the analytical and clinical performance of the Elecsys (R) CA 15-3 immunoassay, CLIN CHEM, 47(12), 2001, pp. 2162-2164
Authors:
Wichmann, MW
Muller, C
Lau-Werner, U
Strauss, T
Lang, RA
Hornung, HM
Stieber, P
Schildberg, FW
Citation: Mw. Wichmann et al., The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer, LANG ARCH S, 385(4), 2000, pp. 271-275
Authors:
Wichmann, MW
Lau-Werner, U
Muller, C
Hornung, HM
Stieber, P
Schildberg, FW
Citation: Mw. Wichmann et al., Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer, ANTICANC R, 20(6D), 2000, pp. 4953-4955
Authors:
Reiter, W
Stieber, P
Reuter, C
Nagel, D
Lau-Werner, U
Lamerz, R
Citation: W. Reiter et al., Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer, ANTICANC R, 20(6D), 2000, pp. 5195-5198
Authors:
Holubec, L
Topolcan, O
Pikner, R
Pecen, L
Vaclavickova, J
Wirthova, M
Molacek, J
Stieber, P
Holdenrieder, S
Sen, LH
Finek, J
Citation: L. Holubec et al., The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence, ANTICANC R, 20(6D), 2000, pp. 5237-5244
Citation: P. Stieber et al., Simple approach to characterizing a pollution event return period in urbanhydrology, by means of hydrological parameters, HYDRO SCI J, 44(2), 1999, pp. 183-198
Authors:
Heinemann, V
Schermuly, MM
Stieber, P
Schulz, L
Jungst, D
Wilkowski, R
Schalhorn, A
Citation: V. Heinemann et al., CA19-9: A pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin, ANTICANC R, 19(4A), 1999, pp. 2433-2435
Authors:
Hasholzner, U
Stieber, P
Reiter, W
Zimmermann, A
Hofmann, K
Schalhorn, A
Citation: U. Hasholzner et al., CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer, ANTICANC R, 19(4A), 1999, pp. 2477-2480
Authors:
Lamerz, R
Runge, M
Stieber, P
Meissner, E
Citation: R. Lamerz et al., Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases, ANTICANC R, 19(4A), 1999, pp. 2489-2493
Authors:
Ebeling, FC
Schmitt, UM
Untch, M
Nagel, D
Fateh-Moghadam, A
Stieber, P
Seidel, D
Citation: Fc. Ebeling et al., Tumour markers CEA and CA 15-3 as prognostic factors in breast cancer - Univariate and multivariate analysis, ANTICANC R, 19(4A), 1999, pp. 2545-2550
Authors:
Stieber, P
Zimmermann, A
Reinmiedl, J
Muller, C
Hoffmann, H
Dienemann, H
Citation: P. Stieber et al., CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC), ANTICANC R, 19(4A), 1999, pp. 2665-2668
Authors:
Stieber, P
Dienemann, H
Schalhorn, A
Schmitt, UM
Reinmiedl, J
Hofmann, K
Yamaguchi, K
Citation: P. Stieber et al., Pro-gastrin-releasing peptide (ProGRP) - A useful marker in small cell lung carcinomas, ANTICANC R, 19(4A), 1999, pp. 2673-2678
Authors:
Schmitt, UM
Stieber, P
Jungst, D
Bilzer, M
Wachtler, M
Heberger, S
Seidel, D
Citation: Um. Schmitt et al., Carbohydrate deficient transferrin is not a useful marker for the detection of chronic alcohol abuse, EUR J CL IN, 29(10), 1999, pp. 901-901